Dutch company Micreos launches first non-antibiotic treatment for MRSA, Staphefekt

08 Nov 2014

Micreos says Endolysin Staphefekt was the first such treatment available for human use on intact skin that had multiple benefits as compared to antibiotics

J&J Pte acquires ORSLTM ready-to-drink electrolyte brand from Jagdale Industries

08 Nov 2014

Botox maker Allergan in talks with new suitor

07 Nov 2014

Allergan did not name the proposed new suitor, which some media reports speculated might be Actavis Inc

Perrigo Co to buy Belgian pharmaceutical firm Omega Pharma for $4.5 bn

06 Nov 2014

US private-label over the counter medicines maker Perrigo today struck a deal to buy Belgian pharmaceutical company Omega in a bid to expand in Europe

AstraZeneca strikes three oncology deals

04 Nov 2014

British pharmaceutical company AstraZeneca today struck three deals to strengthen its oncology business

Wockhardt Q2 net plunges 97% on US export ban

04 Nov 2014

Perrigo in exclusive talks to buy Belgian pharmaceutical company Omega Pharma

01 Nov 2014

Cipla wants Novartis’s patents on respiratory drug revoked

30 Oct 2014

Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease

Ranbaxy reports first profit in six quarters with Rs477.75-cr Q2-FY’15 net

28 Oct 2014

Merck oncology drug wins ‘breakthrough’ classification by US regulators

28 Oct 2014

Keytruda, Merck & Co's flagship new drug, forms part of a new generation of oncology treatments that use the body’s own immune system to attack and destroy tumours

View details about the software product Informachine News Trackers